Catalyst Wire Dossier Catalyst Wire Dossier

Onivyde pegylated liposomal irinotecan

irinotecan anhydrous free-base · Les Laboratoires Servier
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Onivyde pegylated liposomal irinotecan, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: EMA Authorised: Onivyde pegylated liposomal (previously Onivyde) (irinotecan anhydrous free-base) — Les Laboratoires Servier

See pricing